Adovate Revenue and Competitors
Estimated Revenue & Valuation
- Adovate's estimated annual revenue is currently $5.4M per year.
- Adovate's estimated revenue per employee is $201,000
Employee Data
- Adovate has 27 Employees.
- Adovate grew their employee count by 50% last year.
Adovate's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | VP, Chemistry | Reveal Email/Phone |
4 | Project Manager | Reveal Email/Phone |
5 | Operations Manager | Reveal Email/Phone |
6 | Research Associate | Reveal Email/Phone |
Adovate Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is Adovate?
Adovate develops novel drugs that target adenosine receptors involved in major diseases. These drug candidates have been created using our next-generation adenosine drug development platform, which enable design of patented compounds with favorable physiochemical characteristics and distribution kinetics that historically limited drugs acting against the adenosine receptors.
keywords:N/AN/A
Total Funding
27
Number of Employees
$5.4M
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.8M | 27 | 0% | $122.8M |
#2 | $4.6M | 27 | 0% | N/A |
#3 | $4.8M | 27 | -4% | N/A |
#4 | $2.7M | 27 | N/A | N/A |
#5 | $2.7M | 27 | N/A | N/A |